{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"36"}],"units":"Participants"}],"description":"patients are evaluable for their cause of death at Day 100","groups":[{"description":"All patients receive a hematopoietic stem cell transplant using one of two chemotherapy regimens based on disease type","id":"OG000","title":"Hematopoietic Stem Cell Transplantation"}],"paramType":"NUMBER","populationDescription":"36 patients underwent hematopoietic stem cell transplant and therefore were eligible for evaluation of non-relapse mortality at Day 100","reportingStatus":"POSTED","timeFrame":"Day 100","title":"Non-relapse Mortality at Day 100","type":"SECONDARY","unitOfMeasure":"participants"}